Versuchen GOLD - Frei
Smartphone sector hits road to revival with budget models
Mint Chennai
|February 18, 2025
Every time you buy a smartphone, the tech specs you get at a certain price level multiply from the previous buy. This percolation of high tech to lower-priced gadgets sparked a rush for budget smartphones priced below ₹20,000 in the past year, a trend that industry insiders expect to continue in 2025.
The revival comes in the backdrop of a slowdown in sales of smartphones in recent years. Overall smartphone sales in India grew just 4% in 2024 year-on-year (y-o-y) after being stagnant the previous year, according to market researcher International Data Corp (IDC) India.
However, sales of phones priced at ₹20,000 and below sold 35% more in 2024 compared to 2023. Further, sales doubled y-o-y in 2024 for 5G-enabled smartphones priced under ₹20,000.
To be sure, 5G-enabled phones accounted for four out of every five smartphones sold in India last year, while almost one in every two 5G phones sold last year was from the budget segment.
Smartphone brands and sellers expect this trend would continue in 2025, reviving interest in one of the largest electronics categories in the country. Phones priced below ₹20,000 comprise the biggest revenue driver in an industry that generated nearly $40 billion in revenue last year—that's nearly 30% of the domestic electronics industry's annual revenue right now.
Diese Geschichte stammt aus der February 18, 2025-Ausgabe von Mint Chennai.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint Chennai
Mint Chennai
Lenskart wants artificial intelligence to test your eyes
It expects AI-enabled eye testing to become the default foundational layer of eyecare delivery
3 mins
January 13, 2026
Mint Chennai
More companies to take a hit as labour codes debut
Reworked gratuity and leave encashments spell additional expenses for India Inc
2 mins
January 13, 2026
Mint Chennai
HC lifts ban on Zydus cancer biosimilar till patent expiry
In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.
2 mins
January 13, 2026
Mint Chennai
Trump’s investigation of Powell is also a warning to the next Fed chair
The criminal investigation into Federal Reserve Chair Jerome Powell isn’t ultimately about the Fed’s headquarters, or Powell, or even interest rates.
3 mins
January 13, 2026
Mint Chennai
States flag Almont-Kid syrup as tests find contaminants
Syrup found ‘Not of Standard Quality’ with contaminants like toxic ethylene glycol
1 mins
January 13, 2026
Mint Chennai
India at 100: Our choices today will define the next two decades
India's 2047 ambition is not guaranteed but achievable if we address all the potential pitfalls along our development path
4 mins
January 13, 2026
Mint Chennai
Now, inheritance works without probate—but why it still matters
Heirs can now act on a valid will without court cases, easing delays and unlocking assets in undisputed cases
6 mins
January 13, 2026
Mint Chennai
Why VCs have a new deep-tech playbook
where fundraising starts to drag,\" said Chand.
1 min
January 13, 2026
Mint Chennai
TCS, HCLTech deliver Q3 revenue surprise
clearer.
2 mins
January 13, 2026
Mint Chennai
US productivity is rising and it risks warping monetary policy
America's neutral rate ought to be going up but will the Fed listen?
3 mins
January 13, 2026
Listen
Translate
Change font size
